Evaluation of the effect of smokeless tobacco purified products and extracts on latent Epstein-Barr virus.

[1]  D. Saranath,et al.  Epstein-Barr virus in tobacco-induced oral cancers and oral lesions in patients from India. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[2]  S. Hilsenbeck,et al.  Immunofluorescence Microscopy and Flow Cytometry Characterization of Chemical Induction of Latent Epstein-Barr Virus , 1998, Clinical Diagnostic Laboratory Immunology.

[3]  M. Djordjevic,et al.  Chemical Composition and Carcinogenicity of Smokeless Tobacco , 1997, Advances in dental research.

[4]  L. Kingsley,et al.  Detection of Kaposi's sarcoma herpesvirus DNA in semen of homosexual men with Kaposi's sarcoma. , 1996, AIDS.

[5]  N. Raab-Traub.  Epstein-Barr virus: The virus and its tumorigenicity in the normal and immunocompromised host , 1996 .

[6]  M. Moyer,et al.  Attenuation of the natural course of herpes simplex virus infection in human oral epithelial cell cultures by smokeless tobacco extracts suggests the possibility of a synergistic mechanism for carcinogenesis. , 1996, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[7]  P. Biberfeld,et al.  Epstein-Barr virus (EBV) DNA in saliva and EBV serology of HIV-1-infected persons with and without hairy leukoplakia. , 1995, The Journal of infection.

[8]  M. Djordjevic,et al.  Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans. , 1994, Journal of toxicology and environmental health.

[9]  M. Moyer,et al.  Morphologic and growth effects of tobacco-associated chemical carcinogens and smokeless tobacco extracts on human oral epithelial cells in culture. , 1993, Oral surgery, oral medicine, and oral pathology.

[10]  V. Sanchez,et al.  Detection of two early gene products of Epstein-Barr virus by fluorescence flow cytometry. , 1993, Viral immunology.

[11]  L. Kingsley,et al.  Frequent oropharyngeal shedding of Epstein‐Barr virus in homosexual men during early HIV infection , 1992, AIDS.

[12]  K. Hayashi.  Effect of protein kinase C inhibitors with different action mechanisms on Epstein-Barr virus replication. , 1992, Intervirology.

[13]  N. Park,et al.  Synergism of herpes simplex virus and tobacco-specific N'-nitrosamines in cell transformation. , 1991, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[14]  M. Billett,et al.  Preferential binding of the carcinogen benzo[a]pyrene to proteins of the nuclear matrix. , 1991, Carcinogenesis.

[15]  H. Bartsch,et al.  Epstein-Barr virus activators, mutagens and volatile nitrosamines in preserved food samples from high-risk areas for nasopharyngeal carcinoma. , 1991, IARC scientific publications.

[16]  S. Hecht,et al.  Nicotine-derived N-nitrosamines (TSNA) and their relevance in tobacco carcinogenesis. , 1991, Critical reviews in toxicology.

[17]  S. Murphy,et al.  Comparative metabolism of N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by cultured F344 rat oral tissue and esophagus. , 1990, Cancer research.

[18]  J. Sciubba,et al.  Hairy leukoplakia: an AIDS-associated opportunistic infection. , 1989, Oral surgery, oral medicine, and oral pathology.

[19]  R. S. Tan,et al.  Induction of virus enzymes by phorbol esters and n-butyrate in Epstein-Barr virus genome-carrying Raji cells. , 1987, Cancer research.

[20]  T. Iftner,et al.  Enhancement of Epstein-Barr virus membrane protein (LMP) expression by serum, TPA, or n-butyrate in latently infected Raji cells. , 1987, Virology.

[21]  R. S. Tan,et al.  Demonstration of Epstein-Barr virus-specific DNA polymerase in chemically induced Raji cells and its antibody in serum from patients with nasopharyngeal carcinoma. , 1986, Cancer research.

[22]  S. Hecht,et al.  Induction of oral cavity tumors in F344 rats by tobacco-specific nitrosamines and snuff. , 1986, Cancer research.

[23]  G. Lenoir,et al.  Epstein-Barr virus-specific DNA polymerase in virus-nonproducer Raji cells , 1986, Journal of virology.

[24]  T. Sairenji,et al.  Differential effect of TPA and n‐butyrate on induction of Ii and EBV antigens in the P3HR‐1 lymphoblastoid cell line , 1984, Hematological oncology.

[25]  Y. Ito,et al.  A short-term in vitro assay for promoter substances using human lymphoblastoid cells latently infected with Epstein-Barr virus. , 1981, Cancer letters.

[26]  G. Klein,et al.  Immunochemical Characterization of Epstein-Barr Virus-Associated Early and Late Antigens in n-Butyrate-Treated P3HR-1 Cells , 1979, Journal of virology.

[27]  G. Klein,et al.  Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. , 1979, Virology.

[28]  H. Hausen,et al.  Persisting oncogenic herpesvirus induced by the tumour promoter TPA , 1978, Nature.

[29]  M. Sullivan,et al.  Oropharyngeal excretion of Epstein-Barr virus by patients with lymphoproliferative disorders and by recipients of renal homografts. , 1978, Annals of internal medicine.

[30]  E. Kieff,et al.  Complexity of EBV homologous DNA in continuous lymphoblastoid cell lines. , 1976, Virology.

[31]  G. Miller,et al.  Infectious mononucleosis. Epstein-Barr-virus shedding in saliva and the oropharynx. , 1976, The New England journal of medicine.

[32]  C. Abildgaard,et al.  Prevalence of oropharyngeal excreters of leukocyte-transforming agents among a human population. , 1973, The New England journal of medicine.

[33]  G. Miller,et al.  Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis. , 1973, The New England journal of medicine.

[34]  J. Pagano,et al.  Separation of Epstein-Barr virus DNA from large chromosomal DNA in non-virus-producing cells. , 1972, Nature: New biology.

[35]  P. Gerber.  Activation of Epstein-Barr virus by 5-bromodeoxyuridine in "virus-free" human cells (complement-fixing antigen-immunofluorescence-leukocytes). , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[36]  J. G. Derge,et al.  Persistence of a repressed Epstein-Barr virus genome in Burkitt lymphoma cells made resistant to 5-bromodeoxyuridine. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[37]  W. Henle,et al.  Differential Reactivity of Human Serums with Early Antigens Induced by Epstein-Barr Virus , 1970, Science.

[38]  M. Epstein,et al.  Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji). , 1966, Journal of the National Cancer Institute.

[39]  R. Pulvertaft.  A study of malignant tumours in Nigeria by short-term tissue culture , 1965, Journal of clinical pathology.